Volatility Shares Trust 2x Ether ETF

Direxion Daily TSLA Bull 1.5X Shares

GraniteShares 1.5x Long NVDA Daily ETF

GraniteShares 2x Long AMZN Daily ETF

AXS 2X Innovation ETF

GraniteShares 1.5x Long META Daily ETF

Direxion Daily Technology Bull 3X ETF

Bank Of Montreal MAX S&P 500 4X Leveraged ETNs due October 30

Bank Of Montreal

ProShares Ultra Silver

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Technology Bear 3X Shares

VS TR 2x Long VIX Futures ETF

ProShares UltraShort Silver

Direxion Daily Gold Miners Bull 3X ETF

Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P 500 Bear 3X ETF

Direxion Daily Financial Bull 3X ETF

AGM Group Holdings Inc. Class A Ordinary Shares

Ensysce Biosciences Inc. Common Stock

Jayud Global Logistics Limited Class A Ordinary Shares

Sonoma Pharmaceuticals Inc. Common Stock

AgriFORCE  Growing Systems Ltd. Common Shares

Bit Origin Limited Ordinary Shares

Pegasystems Inc. Common Stock

MIND Technology Inc. Common Stock (DE)

Upexi Inc. Common Stock

Novavax Inc. Common Stock

Gelteq Limited Ordinary Shares

Alaska Air Group Inc. Common Stock

International Business Machines Corporation Common Stock

Old Dominion Freight Line Inc. Common Stock

Plug Power Inc. Common Stock

Applied Optoelectronics Inc. Common Stock

Brunswick Corporation Common Stock

Five Below Inc. Common Stock

Enphase Energy Inc. Common Stock

Stifel Financial Corporation Common Stock

Click here to get full coverage on Alaska Airlines warns of slower demand as second-quarter profit outlook falls short - CNBC

Alaska Airlines warns of slower demand as second-quarter profit outlook falls short  CNBC

Alaska Airlines warns of slower demand as second-quarter profit outlook falls short - CNBC

Click here to get full coverage on ALASKA AIR Earnings Results: $ALK Reports Quarterly Earnings - Nasdaq

ALASKA AIR Earnings Results: $ALK Reports Quarterly Earnings  Nasdaq

ALASKA AIR Earnings Results: $ALK Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on Alaska Air Group (ALK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo

Alaska Air Group (ALK) Reports Q1 Loss, Lags Revenue Estimates  Yahoo

Alaska Air Group (ALK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo

Click here to get full coverage on ALK Abello’s Itulazax gets European approval for children - The Pharma Letter

ALK Abello’s Itulazax gets European approval for children  The Pharma Letter

ALK Abello’s Itulazax gets European approval for children - The Pharma Letter

Click here to get full coverage on Alaska Air Group (ALK) Reports Q1 2025 Financial Results - GuruFocus

Alaska Air Group (ALK) Reports Q1 2025 Financial Results  GuruFocus

Alaska Air Group (ALK) Reports Q1 2025 Financial Results - GuruFocus

Click here to get full coverage on Alaska Air Group (ALK) Misses Q1 EPS by 6c; Guides Q2 Lower - StreetInsider

Alaska Air Group (ALK) Misses Q1 EPS by 6c; Guides Q2 Lower  StreetInsider

Alaska Air Group (ALK) Misses Q1 EPS by 6c; Guides Q2 Lower - StreetInsider

Click here to get full coverage on Alaska Air Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga

Alaska Air Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call  Benzinga

Alaska Air Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga

Click here to get full coverage on RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer - Nature

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer  Nature

RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer - Nature

Click here to get full coverage on Incorporating Recent Updates in the Treatment of Metastatic ALK-Positive NSCLC - OncLive

Incorporating Recent Updates in the Treatment of Metastatic ALK-Positive NSCLC  OncLive

Incorporating Recent Updates in the Treatment of Metastatic ALK-Positive NSCLC - OncLive

Click here to get full coverage on Nuvalent describes new ROS and ALK tyrosine kinase receptor inhibitors - BioWorld MedTech

Nuvalent describes new ROS and ALK tyrosine kinase receptor inhibitors  BioWorld MedTech

Nuvalent describes new ROS and ALK tyrosine kinase receptor inhibitors - BioWorld MedTech

Click here to get full coverage on Alaska Air (ALK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo

Alaska Air (ALK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates  Yahoo

Alaska Air (ALK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo

Click here to get full coverage on Alaska Airlines Dominates San Diego: 44 Nonstop Routes, Major Expansion to Chicago, Denver, Phoenix - Stock Titan

Alaska Airlines Dominates San Diego: 44 Nonstop Routes, Major Expansion to Chicago, Denver, Phoenix  Stock Titan

Alaska Airlines Dominates San Diego: 44 Nonstop Routes, Major Expansion to Chicago, Denver, Phoenix - Stock Titan

Click here to get full coverage on Ten Years of Advances: The Story of an ALK-Positive Lung Cancer Survivor - Yale School of Medicine

Ten Years of Advances: The Story of an ALK-Positive Lung Cancer Survivor  Yale School of Medicine

Ten Years of Advances: The Story of an ALK-Positive Lung Cancer Survivor - Yale School of Medicine

Click here to get full coverage on Alaska Air (ALK) Reports Q1 Results, Faces Cost Pressures in Q2 Outlook - GuruFocus

Alaska Air (ALK) Reports Q1 Results, Faces Cost Pressures in Q2 Outlook  GuruFocus

Alaska Air (ALK) Reports Q1 Results, Faces Cost Pressures in Q2 Outlook - GuruFocus

Click here to get full coverage on ALK in cancer: from function to therapeutic targeting - Nature

ALK in cancer: from function to therapeutic targeting  Nature

ALK in cancer: from function to therapeutic targeting - Nature

Click here to get full coverage on Alaska Air Group reports first quarter 2025 results | ALK Stock News - GuruFocus

Alaska Air Group reports first quarter 2025 results | ALK Stock News  GuruFocus

Alaska Air Group reports first quarter 2025 results | ALK Stock News - GuruFocus

Click here to get full coverage on Insights Into Alaska Air (ALK) Q1: Wall Street Projections for Key Metrics - Yahoo Finance

Insights Into Alaska Air (ALK) Q1: Wall Street Projections for Key Metrics  Yahoo Finance

Insights Into Alaska Air (ALK) Q1: Wall Street Projections for Key Metrics - Yahoo Finance

Click here to get full coverage on IBM (IBM) Shares Drop Amid Mixed Tech Sector Performance Post-Earnings | ALK Stock News - GuruFocus

IBM (IBM) Shares Drop Amid Mixed Tech Sector Performance Post-Earnings | ALK Stock News  GuruFocus

IBM (IBM) Shares Drop Amid Mixed Tech Sector Performance Post-Earnings | ALK Stock News - GuruFocus

Click here to get full coverage on Elevated Options Activity Surrounds Alaska Air (ALK) Ahead of Earnings Release | ALK Stock News - GuruFocus

Elevated Options Activity Surrounds Alaska Air (ALK) Ahead of Earnings Release | ALK Stock News  GuruFocus

Elevated Options Activity Surrounds Alaska Air (ALK) Ahead of Earnings Release | ALK Stock News - GuruFocus

Click here to get full coverage on Chipotle Mexican Grill (CMG) Earnings Report: Market Awaits Financial Results | ALK Stock News - GuruFocus

Chipotle Mexican Grill (CMG) Earnings Report: Market Awaits Financial Results | ALK Stock News  GuruFocus

Chipotle Mexican Grill (CMG) Earnings Report: Market Awaits Financial Results | ALK Stock News - GuruFocus

Click here to get full coverage on Alaska Air Group (ALK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Alaska Air Group (ALK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release  Yahoo Finance

Alaska Air Group (ALK) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

Click here to get full coverage on Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug tolerance - Nature

Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug tolerance  Nature

Oncogenic EML4-ALK assemblies suppress growth factor perception and modulate drug tolerance - Nature

Click here to get full coverage on Alaska Air (ALK) Soars 22.6%: Is Further Upside Left in the Stock? - Yahoo Finance

Alaska Air (ALK) Soars 22.6%: Is Further Upside Left in the Stock?  Yahoo Finance

Alaska Air (ALK) Soars 22.6%: Is Further Upside Left in the Stock? - Yahoo Finance

Click here to get full coverage on Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer - Nature

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer  Nature

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK-driven non-small cell lung cancer - Nature

Click here to get full coverage on Integrating Lorlatinib Into First-Line ALK-Positive NSCLC Treatment - Cancer Network

Integrating Lorlatinib Into First-Line ALK-Positive NSCLC Treatment  Cancer Network

Integrating Lorlatinib Into First-Line ALK-Positive NSCLC Treatment - Cancer Network

Click here to get full coverage on New terminal neighbors: Alaska and Hawaiian Airlines align operations | ALK Stock News - GuruFocus

New terminal neighbors: Alaska and Hawaiian Airlines align operations | ALK Stock News  GuruFocus

New terminal neighbors: Alaska and Hawaiian Airlines align operations | ALK Stock News - GuruFocus

Click here to get full coverage on Validea Detailed Fundamental Analysis - ALK - Nasdaq

Validea Detailed Fundamental Analysis - ALK  Nasdaq

Validea Detailed Fundamental Analysis - ALK - Nasdaq

Click here to get full coverage on Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer | Cell Death & Disease - Nature

Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer | Cell Death & Disease  Nature

Novel selective strategies targeting the BCL-2 family to enhance clinical efficacy in ALK-rearranged non-small cell lung cancer | Cell Death & Disease - Nature

Click here to get full coverage on Here's Why Alaska Air Group (ALK) Fell More Than Broader Market - Yahoo Finance

Here's Why Alaska Air Group (ALK) Fell More Than Broader Market  Yahoo Finance

Here's Why Alaska Air Group (ALK) Fell More Than Broader Market - Yahoo Finance

Click here to get full coverage on Treatment of Metastatic ALK-Positive Non-Small Cell Lung Cancer: Indirect Comparison of Different ALK Inhibitors Using Reconstructed Patient Data - Frontiers

Treatment of Metastatic ALK-Positive Non-Small Cell Lung Cancer: Indirect Comparison of Different ALK Inhibitors Using Reconstructed Patient Data  Frontiers

Treatment of Metastatic ALK-Positive Non-Small Cell Lung Cancer: Indirect Comparison of Different ALK Inhibitors Using Reconstructed Patient Data - Frontiers

Click here to get full coverage on ALK Announces New AllerTest™ Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis - PR Newswire

ALK Announces New AllerTest™ Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis  PR Newswire

ALK Announces New AllerTest™ Allergy Skin Testing Devices for Optimized Allergy Testing and Diagnosis - PR Newswire

Click here to get full coverage on Allergy Shots Market Is Booming So Rapidly with ALK-Abelló, Stallergenes Greer - openPR.com

Allergy Shots Market Is Booming So Rapidly with ALK-Abelló, Stallergenes Greer  openPR.com

Allergy Shots Market Is Booming So Rapidly with ALK-Abelló, Stallergenes Greer - openPR.com

Click here to get full coverage on New collaborative effort aims to cure ALK-positive lung cancer - News-Medical

New collaborative effort aims to cure ALK-positive lung cancer  News-Medical

New collaborative effort aims to cure ALK-positive lung cancer - News-Medical

Click here to get full coverage on Is Alaska Air Group, Inc. (ALK) the Best Airline Stock to Buy Now? - Yahoo Finance

Is Alaska Air Group, Inc. (ALK) the Best Airline Stock to Buy Now?  Yahoo Finance

Is Alaska Air Group, Inc. (ALK) the Best Airline Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on Why Insiders Are Selling Alaska Air Group, Inc. (ALK) Recently - Yahoo Finance

Why Insiders Are Selling Alaska Air Group, Inc. (ALK) Recently  Yahoo Finance

Why Insiders Are Selling Alaska Air Group, Inc. (ALK) Recently - Yahoo Finance

Click here to get full coverage on Evaluating ALK Inhibitors in Treatment Sequencing and Testing - Cancer Network

Evaluating ALK Inhibitors in Treatment Sequencing and Testing  Cancer Network

Evaluating ALK Inhibitors in Treatment Sequencing and Testing - Cancer Network

Click here to get full coverage on Development of a TBK1 and ALK dual inhibitor for alleviating depressive behavior via anti-inflammatory effects - ScienceDirect.com

Development of a TBK1 and ALK dual inhibitor for alleviating depressive behavior via anti-inflammatory effects  ScienceDirect.com

Development of a TBK1 and ALK dual inhibitor for alleviating depressive behavior via anti-inflammatory effects - ScienceDirect.com

Click here to get full coverage on Combined utility of genomic breakpoints and frame is a reliable predictor of ALK transcript function - Nature

Combined utility of genomic breakpoints and frame is a reliable predictor of ALK transcript function  Nature

Combined utility of genomic breakpoints and frame is a reliable predictor of ALK transcript function - Nature

Click here to get full coverage on HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy - Nature

HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy  Nature

HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapy - Nature

Click here to get full coverage on Alaska Air Group, Inc. (NYSE:ALK): Industry Tailwinds to Propel Business - Yahoo Finance

Alaska Air Group, Inc. (NYSE:ALK): Industry Tailwinds to Propel Business  Yahoo Finance

Alaska Air Group, Inc. (NYSE:ALK): Industry Tailwinds to Propel Business - Yahoo Finance

Click here to get full coverage on Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025 - PR Newswire

Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025  PR Newswire

Nuvalent to Present New Preclinical Data on ALK-Selective Inhibitor, Neladalkib, and ROS1-Selective Inhibitor, Zidesamtinib, at AACR Annual Meeting 2025 - PR Newswire

Click here to get full coverage on FDA Approves Ensartinib in ALK-Positive NSCLC - Targeted Oncology

FDA Approves Ensartinib in ALK-Positive NSCLC  Targeted Oncology

FDA Approves Ensartinib in ALK-Positive NSCLC - Targeted Oncology

Click here to get full coverage on Here's Why Alaska Air Group (ALK) is a Strong Value Stock - Yahoo Finance

Here's Why Alaska Air Group (ALK) is a Strong Value Stock  Yahoo Finance

Here's Why Alaska Air Group (ALK) is a Strong Value Stock - Yahoo Finance

Click here to get full coverage on Lorbrena Effective as Initial Treatment of ALK-Positive NSCLC - National Cancer Institute (.gov)

Lorbrena Effective as Initial Treatment of ALK-Positive NSCLC  National Cancer Institute (.gov)

Lorbrena Effective as Initial Treatment of ALK-Positive NSCLC - National Cancer Institute (.gov)

Click here to get full coverage on Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer - Nature

Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer  Nature

Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer - Nature

Click here to get full coverage on ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States - GlobeNewswire

ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States  GlobeNewswire

ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States - GlobeNewswire

Click here to get full coverage on Is Alaska Air Group (ALK) Outperforming Other Transportation Stocks This Year? - Yahoo Finance

Is Alaska Air Group (ALK) Outperforming Other Transportation Stocks This Year?  Yahoo Finance

Is Alaska Air Group (ALK) Outperforming Other Transportation Stocks This Year? - Yahoo Finance

Click here to get full coverage on First Approval for New ALK Inhibitor - American Association for Cancer Research (AACR)

First Approval for New ALK Inhibitor  American Association for Cancer Research (AACR)

First Approval for New ALK Inhibitor - American Association for Cancer Research (AACR)

Click here to get full coverage on ALK Stock Up 12.1% on Q4 Earnings: Time to Buy? - Yahoo Finance

ALK Stock Up 12.1% on Q4 Earnings: Time to Buy?  Yahoo Finance

ALK Stock Up 12.1% on Q4 Earnings: Time to Buy? - Yahoo Finance

Click here to get full coverage on Flying at 30,000 Feet High’: Jim Cramer’s Bullish Call on Alaska Air Group, Inc. (ALK) - Yahoo Finance

Flying at 30,000 Feet High’: Jim Cramer’s Bullish Call on Alaska Air Group, Inc. (ALK)  Yahoo Finance

Flying at 30,000 Feet High’: Jim Cramer’s Bullish Call on Alaska Air Group, Inc. (ALK) - Yahoo Finance

Click here to get full coverage on Cooperative blockade of FLT3 and ALK synergistically suppresses growth of osteosarcoma | Oncogene - Nature

Cooperative blockade of FLT3 and ALK synergistically suppresses growth of osteosarcoma | Oncogene  Nature

Cooperative blockade of FLT3 and ALK synergistically suppresses growth of osteosarcoma | Oncogene - Nature

Click here to get full coverage on Alaska Air Group (ALK) Stock Moves -0.18%: What You Should Know - Yahoo Finance

Alaska Air Group (ALK) Stock Moves -0.18%: What You Should Know  Yahoo Finance

Alaska Air Group (ALK) Stock Moves -0.18%: What You Should Know - Yahoo Finance

Click here to get full coverage on Strategic and Safe Lorlatinib Use Is Key to Optimal ALK+ NSCLC Management - OncLive

Strategic and Safe Lorlatinib Use Is Key to Optimal ALK+ NSCLC Management  OncLive

Strategic and Safe Lorlatinib Use Is Key to Optimal ALK+ NSCLC Management - OncLive

Click here to get full coverage on FDA Approval of Ensartinib for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) - Business Wire

FDA Approval of Ensartinib for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)  Business Wire

FDA Approval of Ensartinib for ALK-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) - Business Wire

Click here to get full coverage on Alaska Airlines continues to grow in San Diego with a 30% increase in flights and three new nonstop destinations | ALK Stock News - GuruFocus

Alaska Airlines continues to grow in San Diego with a 30% increase in flights and three new nonstop destinations | ALK Stock News  GuruFocus

Alaska Air Group Inc (ALK)

Price Chart

Key Statistics

Technicals

About ALK

Latest News

Alaska Airlines warns of slower demand as second-quarter profit outlook falls short - CNBC

ALASKA AIR Earnings Results: $ALK Reports Quarterly Earnings - Nasdaq

Alaska Air Group (ALK) Reports Q1 Loss, Lags Revenue Estimates - Yahoo

Advanced Charts

Top Gainers

Top Losers